Low-concentration atropine has side effects in the treatment of myopia. At present, low-concentration atropine is gradually becoming the first-line drug for myopia control in adolescents. Compared with the medium-concentration 0.5% atropine and the higher-concentration 1% atropine used in the past, low-concentration atropine with a drug composition of only 0.01% is relatively safer.
However, there are some patients who have shown mild or severe side effects with low concentrations of atropine. These include blurred vision, decreased vision, photophobia, excessive sweating, eye congestion, dry mouth and dry throat.
It is worth noting that low concentration atropine is only indicated for the treatment of pseudomyopia and has no therapeutic effect on true myopia. There are also some patients in the clinic who do not have any significant control effect even with intervention of high concentration atropine treatment.